U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
On Oct. 22, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO® (Respiratory…
On Oct. 22, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO® (Respiratory…
On Oct. 21, 2024, scientists from the University of Alabama at Birmingham (UAB) and Iowa State University (ISU)…
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
On Oct. 21, 2024, Rice University’s Baker Institute for Public Policy reported that hospital service prices surged more…
On Oct. 20, 2024, the World Health Organization (WHO) announced it had certified Egypt as malaria-free, marking a…
On Oct. 20, 2024, the Washington State Department of Health announced that four agricultural workers tested positive for…
On Oct. 18, 2024, a study published in JAMA Ophthalmology, found that approximately 4.22 million people in the…
On Oct. 18, 2024, the World Health Organization (WHO) reported that from January 1 to September 29, 2024,…
On Oct. 18, 2024, the California Department of Public Health (CDPH) reported that a total of 13 human…
On Oct. 18, 2024, a research team led by Radboud university medical center reported that a new PET…
On Oct. 17, 2024, Colossal Biosciences, an American biotechnology and genetic engineering company, announced that it has a…
On Oct. 17, 2024, Geisinger announced results of a study that showed increased risk for autism appears to…
On Oct. 17, 2024, a study led by the University at Buffalo and the Jackson Laboratory (JAX) revealed…
On Oct. 16, 2024, The U.S. Food and Drug Administration (FDA) announced it had updated the label for…
On Oct. 16, 2024, researchers from the Wellcome Sanger Institute, Newcastle University and their collaborators announced they had…
On Oct. 16, 2024, Know Labs in Seattle announced that it had retained The Stanbridge Group to secure…
On Oct. 16, 2024, Sanofi announced it will contribute $18 million to three Historically Black Medical Schools to…
On Oct. 16, 2024, a researchers at Copenhagen University Hospital reported in a medical case report that a…
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
On Oct. 15, 2024, Massachusetts Governor Maura Healey and the Massachusetts Life Sciences Center (MLSC) announced $21.4 million…
On Oct. 14, 2024, researchers have found a link between two human-specific genes and the gene SYNGAP1, a…
On Oct. 14, 2024, Lundbeck and Longboard Pharmaceuticals announced an agreement for Lundbeck to acquire Longboard for payment…
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
On Oct, 14, 2024, a team of researchers from the Allen Institute of Brain Science and the University…
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
On Oct. 11, 2024, a team of researchers from University of Illinois Urbana-Champaign announced DNA analysis of the…
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
On Oct. 11, 2024, scientists at the Korea Advanced Institute of Science and Technology (KAIST) announced they had…
On Oct. 11, 2024, researchers in China published a study that provided details about a new wetland virus….